| 臺大學術典藏 |
2021-10-25T02:57:42Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M; |Hong R.-L; |Ting L.-L; |JENG-YUH KO; |Sheen T.-S; |Lou P.-J. |
| 臺大學術典藏 |
2021-10-25T02:57:42Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M; |Chiou C.-R; |JENG-YUH KO; |Sheen T.-S; |Hong R.-L; |Ting L.-L. |
| 臺大學術典藏 |
2021-07-03T03:36:03Z |
Loss of heterozygosity on chromosomes 3 and 11 in a radiation-induced malignant fibrous histiocytoma - Case report
|
Ko J.-Y.; Jou Y.-S.; PEI-JER CHEN; Hsu M.-M. |
| 臺大學術典藏 |
2021-07-03T03:35:46Z |
Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT, p16INK4a, and p19ARF genes in nasopharyngeal carcinoma
|
Ko J.-Y.; Lee T.-C.; Hsiao C.-F.; Lin G.-L.; Yen S.-H.; Chen K.Y.; Hsiung C.A.; PEI-JER CHEN; Hsu M.-M.; Jou Y.-S. |
| 臺大學術典藏 |
2021-05-07T06:02:39Z |
Familial tendency and risk of nasopharyngeal carcinoma in Taiwan: Effects of covariates on risk
|
Hsu W.-L.;Yu K.J.;Chien Y.-C.;Chun-Ju Chiang ;Cheng Y.-J.;Chen J.-Y.;Liu M.-Y.;Chou S.-P.;You S.-L.;Hsu M.-M.;Lou P.-J.;Wang C.-P.;Hong J.-H.;Leu Y.-S.;Tsai M.-H.;Su M.-C.;Tsai S.-T.;Chao W.-Y.;Ger L.-P.;Chen P.-R.;Yang C.-S.;Hildesheim A.;Diehl S.R.;Chen C.-J.; Hsu W.-L.; Yu K.J.; Chien Y.-C.; CHUN-JU CHIANG; Cheng Y.-J.; Chen J.-Y.; Liu M.-Y.; Chou S.-P.; You S.-L.; Hsu M.-M.; Lou P.-J.; Wang C.-P.; Hong J.-H.; Leu Y.-S.; Tsai M.-H.; Su M.-C.; Tsai S.-T.; Chao W.-Y.; Ger L.-P.; Chen P.-R.; Yang C.-S.; Hildesheim A.; Diehl S.R.; Chen C.-J. |
| 臺大學術典藏 |
2021-04-22T06:57:17Z |
Enumeration of lymphocyte subsets before and after concanavalin A stimulation by using flow cytometry in patients with nasopharyngeal carcinoma.
|
Hsu M.M.; Hsu L.W.; PEI-MING YANG |
| 臺大學術典藏 |
2021-03-18T02:03:56Z |
Investigation into allergic response in patients with chronic sinusitis.
|
Liu C.M.; CHIA-TUNG SHUN; Song H.C.; Lee S.Y.; Hsu M.M.; How S.W. |
| 臺大學術典藏 |
2021-03-18T02:03:55Z |
Lymphocyte subsets and antigen-specific IgE antibody in nasal polyps
|
Liu C.-M.; CHIA-TUNG SHUN; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:17Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Ruey-Long Hong;Sheen T.S.;Ko J.Y.;Hsu M.M.;Wang C.C.;Ting L.L.; RUEY-LONG HONG; Sheen T.S.; Ko J.Y.; Hsu M.M.; Wang C.C.; Ting L.L. |
| 臺大學術典藏 |
2021-03-09T06:46:16Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M.;Chiou C.-R.;Ko J.-Y.;Sheen T.-S.;Ruey-Long Hong;Ting L.-L.; Hsu M.-M.; Chiou C.-R.; Ko J.-Y.; Sheen T.-S.; RUEY-LONG HONG; Ting L.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:16Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M.;Ruey-Long Hong;Ting L.-L.;Ko J.-Y.;Sheen T.-S.;Lou P.-J.; Hsu M.-M.; RUEY-LONG HONG; Ting L.-L.; Ko J.-Y.; Sheen T.-S.; Lou P.-J. |
| 臺大學術典藏 |
2021-03-09T06:46:15Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Ruey-Long Hong;Ting L.-L.;Ko J.-Y.;Hsu M.-M.;Sheen T.-S.;Lou P.-J.;Wang C.-C.;Chung N.-N.;Lui L.T.; RUEY-LONG HONG; Ting L.-L.; Ko J.-Y.; Hsu M.-M.; Sheen T.-S.; Lou P.-J.; Wang C.-C.; Chung N.-N.; Lui L.T. |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35
|
Chie W.-C.;Ruey-Long Hong;Lai C.-C.;Ting L.-L.;Hsu M.-M.; Chie W.-C.; RUEY-LONG HONG; Lai C.-C.; Ting L.-L.; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:12Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Ruey-Long Hong;Lin C.-Y.;Ting L.-L.;Ko J.-Y.;Hsu M.-M.; RUEY-LONG HONG; Lin C.-Y.; Ting L.-L.; Ko J.-Y.; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
|
Chan A.T.C.;Hsu M.-M.;Goh B.C.;Hui E.P.;Liu T.-W.;Millward M.J.;Ruey-Long Hong;Whang-Peng J.;Ma B.B.Y.;To K.F.;Mueser M.;Amellal N.;Lin X.;Chang A.Y.; Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. |
| 臺大學術典藏 |
2021-02-02T08:29:56Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; BOR-RU LIN; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:22:37Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:47:06Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Yeong-Shiau Pu;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Hsieh C.-Y.; Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; YEONG-SHIAU PU; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-11-27T08:15:04Z |
Antibodies to Epstein?Barr virus?specific DNase in patients with nasopharyngeal carcinoma and control groups
|
Hu C.?P.; Yang C.?S.; CHANG-YAO HSIEH; Lai M.?Y.; Kuo S.?L.; Chen J.?Y.;Chen C.?J.;Liu M.?Y.;Cho S.?M.;Hsu M.?M.;Lynn T.?C.;Shieh T.;Tu S.?M.;Lee H.?H.;Kuo S.?L.;Lai M.?Y.;Chang-Yao Hsieh;Hu C.?P.;Yang C.?S.; Chen J.?Y.; Chen C.?J.; Liu M.?Y.; Cho S.?M.; Hsu M.?M.; Lynn T.?C.; Shieh T.; Tu S.?M.; Lee H.?H. |
| 臺大學術典藏 |
2020-11-27T08:14:40Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Pu Y.-S.;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Chang-Yao Hsieh; Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; CHANG-YAO HSIEH |
| 臺大學術典藏 |
2020-11-03T15:39:36Z |
Familial tendency and risk of nasopharyngeal carcinoma in Taiwan: Effects of covariates on risk
|
Chen P.-R; Yang C.-S; Hildesheim A; Diehl S.R; Chen C.-J.; Hsu M.-M; Lou P.-J; CHENG-PING WANG; Hong J.-H; Leu Y.-S; Tsai M.-H; Su M.-C; Tsai S.-T; Chao W.-Y; Ger L.-P; Chou S.-P; You S.-L; Chen J.-Y; Liu M.-Y; Cheng Y.-J; Chiang C.-J; Chien Y.-C; Yu K.J; Hsu W.-L |
| 臺大學術典藏 |
2020-11-02T02:05:31Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Hsieh C.-Y.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Ho Y.-F.; Hsu M.-M.; Lin J.-K.; Hsu C.-H.; Chen A.-L. |
| 臺大學術典藏 |
2020-10-27T12:04:52Z |
Increased mutagen sensitivity in patients with head and neck cancer is less pronounced in patients with nasopharyngeal carcinoma
|
Ko J.-Y; Lui L.T; Sheen T.-S; PEI-JEN LOU; Hsu M.-M. |
| 臺大學術典藏 |
2020-10-27T12:04:49Z |
Intracranial relapse of nasopharyngeal carcinoma manifested as sudden deafness
|
Hsu M.-M.; PEI-JEN LOU; Lin C.-Y; Young Y.-H; Young Y.-H;Lin C.-Y;Pei-Jen Lou;Hsu M.-M. |
| 臺大學術典藏 |
2020-10-27T12:04:19Z |
Partial least square discriminant analysis discovered a dietary pattern inversely associated with nasopharyngeal carcinoma risk
|
PEI-JEN LOU; Chen I.-H; Hildesheim A; Chen C.-J.; Hsu M.-M; Chen J.-Y; Chien Y.-C; Lo Y.-L; Pan W.-H; Hsu W.-L |
